These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2525150

  • 1. Immunodeficiency in graft-versus-host disease (GVHD). II. Effects of GVHD-induced suppressor cells on CD4+ T cell clones.
    Wall DA, Hamberg S, Ferrara JL, Abbas AK.
    J Immunol; 1989 Jul 01; 143(1):74-8. PubMed ID: 2525150
    [Abstract] [Full Text] [Related]

  • 2. Induction of graft versus host-associated immunodeficiency by CD4+ T cell clones.
    Tary-Lehmann M, Rolink AG, Lehmann PV, Nagy ZA, Hurtenbach U.
    J Immunol; 1990 Oct 01; 145(7):2092-8. PubMed ID: 1975825
    [Abstract] [Full Text] [Related]

  • 3. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
    Parkman R.
    J Immunol; 1986 May 15; 136(10):3543-8. PubMed ID: 2871104
    [Abstract] [Full Text] [Related]

  • 4. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.
    Wall DA, Hamberg SD, Reynolds DS, Burakoff SJ, Abbas AK, Ferrara JL.
    J Immunol; 1988 May 01; 140(9):2970-6. PubMed ID: 3129505
    [Abstract] [Full Text] [Related]

  • 5. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.
    Wilde DB, Marrack P, Kappler J, Dialynas DP, Fitch FW.
    J Immunol; 1983 Nov 15; 131(5):2178-83. PubMed ID: 6195255
    [Abstract] [Full Text] [Related]

  • 16. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL.
    J Immunol; 1995 Jul 15; 155(2):585-93. PubMed ID: 7608537
    [Abstract] [Full Text] [Related]

  • 17. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M, Via CS, Shearer GM.
    J Immunol; 1988 Jul 15; 141(2):430-9. PubMed ID: 2968400
    [Abstract] [Full Text] [Related]

  • 18. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR.
    Biol Blood Marrow Transplant; 2003 Dec 15; 9(12):742-52. PubMed ID: 14677113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.